Technology area: Semiconductors, Circuits & Optics
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Readycure Inc. is currently prosecuting a patent portfolio within the Semiconductors, Circuits & Optics technology area. The company has 1 pending office action, which is being handled by 1 distinct examiner. This indicates a focused and centralized prosecution environment, where the company's current intellectual property efforts are concentrated on a single active matter before the patent office.
The activity is restricted to 1 distinct art unit, suggesting that the technology under review is specialized within the Semiconductors, Circuits & Optics field. BOOSALIS, FANI POLYZOS is the busiest examiner for this portfolio, with 1 pending office action currently assigned. As the only examiner involved in the company's active filings, their review is the sole factor in the current prosecution landscape.
From a management perspective, the involvement of 1 distinct examiner and 1 distinct art unit simplifies the prosecution process. The total of 1 pending office action means that the company can focus its resources on a single set of examiner requirements. Practitioners should note that the success of the current Semiconductors, Circuits & Optics portfolio depends entirely on the resolution of the 1 pending office action managed by BOOSALIS, FANI POLYZOS.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOOSALIS, FANI POLYZOS | 1 | 90.3% | +10.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18646895 | LOW-DOSE RADIATION TREATMENT SYSTEM FOR NEURODEGENERATIVE DISEASES OR CHRONIC INFLAMMATION OF HUMAN BODY TREATMENT BASED ON PHOTON ENERGY LEVEL | BOOSALIS, FANI POLYZOS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18646895 | LOW-DOSE RADIATION TREATMENT SYSTEM FOR NEURODEGENERATIVE DISEASES OR CHRONIC INFLAMMATION OF HUMAN BODY TREATMENT BASED ON PHOTON ENERGY LEVEL | BOOSALIS, FANI POLYZOS | — |
| Art Unit | Apps |
|---|---|
| 2884 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18646895 | LOW-DOSE RADIATION TREATMENT SYSTEM FOR NEURODEGENERATIVE DISEASES OR CHRONIC INFLAMMATION OF HUMAN BODY TREATMENT BASED ON PHOTON ENERGY LEVEL | BOOSALIS, FANI POLYZOS | 2884 | §103 | Non-Final OA | — | Pending | Apr 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialReadycure Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Fani Polyzos Boosalis has the most, with 1 of Readycure Inc.'s pending office actions.
Mostly Semiconductors, Circuits & Optics (USPTO Tech Center 2800), based on where its pending office actions are examined.
